Edesa Biotech, Inc. (EDSA) stock
EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
$1.96+0.07 (+3.70%)
Close on Nov 17, 2026Market cap $18.90MP/E –Yield –
Edesa Biotech profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Edesa Biotech's profit margin for the twelve months ending Jun 30, 2021 was -2334161.4%. For fiscal 2020 it was -1935.3%, against -2378.6% the year before. The highest annual figure on record is -395.2% in fiscal 2016.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Sep 30, 2020 | -1935.3% | +443.2 |
| FY2018 | Sep 30, 2018 | -2378.6% | −174.9 |
| FY2017 | Sep 30, 2017 | -2203.7% | −1808.4 |
| FY2016 | Sep 30, 2016 | -395.2% | +1872.7 |
| FY2014 | Aug 31, 2014 | -2267.9% | +389.6 |
| FY2013 | Aug 31, 2013 | -2657.5% | −724.5 |
| FY2012 | Aug 31, 2012 | -1932.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -402739.6% | −143938.2 |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -1605.5% | +475.4 |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -1347.9% | +763.7 |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -1015.2% | +5822.1 |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | -258801.4% | −216407.7 |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -2080.8% | +3862.9 |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | -2111.6% | −360.3 |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -6837.2% | −5789.9 |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -42393.7% | −41907.9 |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -5943.7% | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -1751.3% | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -1047.3% | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | -485.8% | – |
See a number that looks wrong?